-
1
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s002Test
https://figshare.com/articles/dataset/table_1_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_PDF/6586289Test -
2
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s001Test
https://figshare.com/articles/dataset/data_sheet_1_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_doc/6586286Test -
3
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s003Test
https://figshare.com/articles/dataset/table_2_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_PDF/6586292Test -
4
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s002Test
https://figshare.com/articles/dataset/table_1_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_PDF/6819491Test -
5
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s003Test
https://figshare.com/articles/dataset/table_2_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_PDF/6819494Test -
6
المؤلفون: M. Fevzi Ozkaynak, Andrew L. Gilman, Wendy B. London, Arlene Naranjo, Mitchell B. Diccianni, Sheena C. Tenney, Malcolm Smith, Karen S. Messer, Robert Seeger, C. Patrick Reynolds, L. Mary Smith, Barry L. Shulkin, Marguerite Parisi, John M. Maris, Julie R. Park, Paul M. Sondel, Alice L. Yu
مصطلحات موضوعية: Immunology, Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies), Autoimmunity, Cellular Immunology, Humoural Immunology and Immunochemistry, Immunogenetics (incl. Genetic Immunology), Innate Immunity, Transplantation Immunology, Tumour Immunology, Immunology not elsewhere classified, Genetic Immunology, Animal Immunology, Veterinary Immunology, neuroblastoma, immunotherapy, anti-GD2 chimeric antibody, cytokines, safety, cytokine biomarkers
الإتاحة: https://doi.org/10.3389/fimmu.2018.01355.s001Test
https://figshare.com/articles/dataset/data_sheet_1_A_Comprehensive_Safety_Trial_of_Chimeric_Antibody_14_18_With_GM-CSF_IL-2_and_Isotretinoin_in_High-Risk_Neuroblastoma_Patients_Following_Myeloablative_Therapy_Children_s_Oncology_Group_Study_ANBL0931_doc/6819488Test